Entellus Medical, Inc. Common Stock
ENTL
ENTL was delisted on the 27th of February, 2018.
56 hedge funds and large institutions have $221M invested in Entellus Medical, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 5 closing their positions.
110% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 10
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
11% more capital invested
Capital invested by funds: $199M → $221M (+$21.9M)
8% more funds holding
Funds holding: 52 → 56 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MRM
Michael R. Murphy
|
+$6.94M |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$4.9M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$2.42M |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$954K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$540K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
-$7.88M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$1.2M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.09M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.08M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$647K |
ENTL Hedge Fund Activity: Q1 2016 in Review
56 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q1 2016, worth a combined $221M — up 11% from $199M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ENTL positions and 5 closed out — a net gain of 4 holders — while 21 added to existing stakes and 10 trimmed.
The largest buyer was Michael R. Murphy, adding an estimated $6.94M. The largest seller was RS Investment Management, exiting entirely with an estimated $7.88M sold.
- 56 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q1 2016, up from 52 in Q4 2015.
- Funds reported $221M of Entellus Medical, Inc. Common Stock stock for Q1 2016, up 11% quarter-over-quarter.
- 9 funds opened new Entellus Medical, Inc. Common Stock positions in Q1 2016 and 5 closed out, a net change of +4 holders.
- The largest Entellus Medical, Inc. Common Stock buyer in Q1 2016 was Michael R. Murphy, an estimated $6.94M added.
- The largest Entellus Medical, Inc. Common Stock seller in Q1 2016 was RS Investment Management, an estimated $7.88M sold.
Based on aggregated 13F filings for Q1 2016.